Skip to main content

This webpage content is intended for Health Care Professionals (HCP’s) only.

I am not a HCP

Intended for Healthcare Professionals

Johnson and Johnson logo graphic link
/en-EMEA
  • biosense webster logo
  • Cerenovus JJMT logo
  • DePuy Synthes Logo
  • Ethicon Logo
  • mentor logo

Intended for HCPs

Intended for Healthcare Professionals

Secondary nav block

Cerenovus Logo
  • Home
  • Products
    • All Products
    • Access
    • Hemorrhagic
    • Ischemic
  • NTI
  • News
  • Support
    • Contact Us
    • J&J Institute
    • Medical Information Request (MIR)

CERENOVUS News & Events

Patrick Brouwer, and 3 colleagues in the lab in white coats

The Neuro Thromboembolic Initiative: Addressing the science behind clots.

07 October 2022
Mahmood Mirza and 4 colleagues in the lab in white coats and masks.

Stroke Science: From Lab to Life. “As research engineers we are inspired by the challenge of enabling physicians to give patients the best possible clinical outcome.”

28 September 2022
EMBOTRAP BANNER

New research shows first pass recanalization in mechanical thrombectomy could deliver environmental benefits whilst improving patient outcomes.

14 April 2022
Stroke Science: From Lab to Life.

Stroke Science: From Lab to Life. “That’s what I want to tell young women: try until you succeed. If you're really passionate about something, don't give up.” Anushree Dwivedi PhD, Research & Development Engineer, CERENOVUS

08 March 2022
sarah johnson holding award

Clot science: from lab to life. “I have seen the devastating impact that stroke can have – so knowing that our devices are helping people really drives me.” Sarah Johnson, PhD.

25 October 2021
cerenovus embotrap

New CERENOVUS study demonstrates cost-savings associated with First-Pass Effect in mechanical thrombectomy for treating acute ischemic stroke in the US and Europe

07 January 2021
CERENOVUS Launches NIMBUS™

CERENOVUS Launches NIMBUS™ Geometric Clot Extractor to Remove Tough Clots

07 October 2020
CERENOVUS Launches New Suite of Technologies to Advance Stroke Treatment

CERENOVUS Launches New Suite of Technologies to Advance Stroke Treatment

09 September 2020
fighting stroke together hero image

Fighting Stroke Together

29 October 2019
First Intracranial Aneurysm Patients Treated with BRAVO Flow Diverter Following European Regulatory Approval

First Intracranial Aneurysm Patients Treated with BRAVO Flow Diverter Following European Regulatory Approval

19 September 2018
  • Load More

CERENOVUS

Johnson and Johnson logo
Johnson & Johnson
  • Privacy Policy
  • Legal Notice
  • Careers
  • J&J Institute
  • Contact
  • Accessibility Statement
  • Cookie Policy
English (EMEA)

All contents © Medical Devices Business Services, Inc. 2021. All Rights Reserved

You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.

Yes, Continue to External Site No, Stay Here